Comparing between Hydroxyurea and Non-Hydroxyurea Anti-inflammatory Cytokines in Sickle Cell Anemia Saudi Patients

被引:0
|
作者
Tarbiah, Nesrin, I [1 ]
Alamri, Reema S. [1 ]
Alkhattabi, Nuha A. [1 ]
Alhemadi, Maryam M. [1 ]
Almutairi, Huda S. [1 ]
Alzahri, Reem Y. [2 ]
Hussain, Hend [3 ]
机构
[1] King Abdulaziz Univ, Dept Biochem, Jeddah, Saudi Arabia
[2] Jeddah Univ, Dept Biol, Jeddah, Saudi Arabia
[3] King Abdulaziz Univ, Dept Hematol, Jeddah, Saudi Arabia
关键词
Anti-inflammatory cytokines; Hydroxyurea; Inflammation; Sickle cell disease; DISEASE PATIENTS; IL-37;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Sickle Cell Anemia (SCA) is a hemolytic deficiency that is typified by strangely formed (sickles) red blood cells that are expelled from circulation at expanded rates, leading to anemia. It is caused by inheritance of hemoglobin (Hb) that has mutated, which compared to adult normal Hb, contains a single amino acid substitution, where at the sixth residue valine substitutes glutamic acid in the Hb tetramer in both of the two B chains. For SCA patients, chronic inflammatory conditions are linked to high levels of inflammation markers, including cytokines and adhesion molecules. Cytokines are a group of small proteins that are essential in cell signaling. The immuno regulatory molecules known as anti-inflammatory cytokines control the response of pro inflammatory and have gained attention recently as anti-inflammatory mediator in SCA patients. The most interesting anti-inflammatory cytokines are IL-10, IL-4, IL-27, and IL-37. This a case-control study aimed to measure the concentrations of the anti-inflammatory cytokines in 3 groups, SCA patients without the use of any medication, SCA patients under Hydroxy Urea therapy (SCAHU), and healthy people (male and female) in the general Saudi population, using a total of 78 chosen subjects. Using ELISA kits, cytokine levels were measured in the plasma of the patients. The results of the study indicated that anti-inflammatory cytokines were elevated in SCA and SCAHU patients when compared to the control (P=0.001), and there were no significant differences between SCA and SCAHU patients. The anti-inflammatory cytokines, including IL-27 and IL-37, that were detected for the first time in SCA patients in KSA in this research, have a role in keeping patients in a steady-state and reducing inflammation, therefore more research to understand the roles of these cytokines in SCA pathology of is essential to allow the development of effective therapies to treat this disease.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [1] Anti-inflammatory effect of hydroxyurea therapy in sickle cell disease.
    Lanaro, Carolina
    Franco-Penteado, Carla F.
    Conran, Nicola
    Saad, Sara T. O.
    Costa, Fernando F.
    BLOOD, 2006, 108 (11) : 27B - 27B
  • [2] Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy
    Lanaro, C.
    Franco-Penteado, C. F.
    Albuqueque, D. M.
    Saad, S. T. O.
    Conran, N.
    Costa, F. F.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 85 (02) : 235 - 242
  • [3] Cytokines and soluble adhesion molecules in sickle cell anemia patients during hydroxyurea therapy
    Saleh, AW
    Duits, AJ
    Gerbers, A
    de Vries, C
    Hillen, HFP
    ACTA HAEMATOLOGICA, 1998, 100 (01) : 26 - 31
  • [4] Hydroxyurea: Why and how I use hydroxyurea to treat young patients with sickle cell anemia
    Pondarre, Corinne
    Soulie, Alizee
    HEMATOLOGIE, 2023, 29 (06): : 354 - 364
  • [5] Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia
    Penkert, Rhiannon R.
    Hurwitz, Julia L.
    Thomas, Paul
    Rosch, Jason
    Dowdy, Jola
    Sun, Yilun
    Tang, Li
    Hankins, Jane S.
    HAEMATOLOGICA, 2018, 103 (02) : E50 - E54
  • [6] Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
    Kabuyi, Paul Lumbala
    Mbayabo, Gloire
    Ngole, Mamy
    Zola, Aime Lumaka
    Race, Valerie
    Matthijs, Gert
    Van Geet, Chris
    Tshilobo, Prosper Lukusa
    Devriendt, Koenraad
    Mikobi, Tite Minga
    EJHAEM, 2023, 4 (03): : 595 - 601
  • [7] Exposure to Hydroxyurea and Pregnancy Outcomes in Patients With Sickle Cell Anemia
    Ballas, Samir K.
    McCarthy, William F.
    Guo, Nan
    DeCastro, Laura
    Bellevue, Rita
    Barton, Bruce A.
    Waclawiw, Myron A.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2009, 101 (10) : 1046 - 1051
  • [8] Predicting the effectiveness of hydroxyurea in individual sickle cell anemia patients
    Valafar, H
    Valafar, F
    Darvill, A
    Albersheim, P
    Kutlar, A
    Woods, KF
    Hardin, J
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2000, 18 (02) : 133 - 148
  • [9] Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia
    Ballas, Samir K.
    Bauserman, Robert L.
    McCarthy, William F.
    Waclawiw, Myron A.
    Barton, Bruce A.
    BLOOD, 2009, 114 (22) : 980 - 980
  • [10] The Impact of Hydroxyurea on Career and Employment of Patients With Sickle Cell Anemia
    Ballas, Samir K.
    Bauserman, Robert L.
    McCarthy, William F.
    Waclawiw, Myron A.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2010, 102 (11) : 993 - 999